Filing Details
- Accession Number:
- 0001209191-15-050802
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-05 19:06:50
- Reporting Period:
- 2015-06-03
- Filing Date:
- 2015-06-05
- Accepted Time:
- 2015-06-05 19:06:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1479290 | Revance Therapeutics Inc. | RVNC | Pharmaceutical Preparations (2834) | 770551645 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1597578 | Curtis Ruegg | C/O Revance Therapeutics, Inc. 7555 Gateway Boulevard Newark CA 94560 | Evp, Technical Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-06-03 | 500 | $6.60 | 18,527 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-06-03 | 500 | $30.00 | 18,027 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-06-03 | 500 | $0.00 | 500 | $6.60 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,836 | 2016-12-11 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 15, 2014.
- The Option is fully vested as of September 29, 2010.
Billionaire Hedge Funds
